Search Tag: Thermo Fisher Scientific
2021 24 Mar
Speakers Valerie Vaughn Director of Hospital Medicine Research in the Division of General Internal Medicine University of Utah, Salt Lake City, USA Neil Powell Consultant Antimicrobial Pharmacist Royal Cornwall Hospitals NHS Trust, Truro, UK Find Thermo Fisher Scientific on Social Media Read more
2021 19 Jan
Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million...Read more
2015 27 Oct
New diagnostic pathway allows instant rule out of Acute Myocardial Infarction (AMI) with a combination of copeptin and troponin The recently released guidelines by the European Society of Cardiology (ESC) suggest that using measurements of copeptin level together with troponin level is the only new diagnostic pathway that allows an instant and...Read more
2015 27 Jul
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has introduced new instruments and assays to expand the use of clinical testing, enhance laboratory productivity and ultimately improve patient outcomes. The new solutions were unveiled at the 2015 AACC Annual Meeting and Clinical Lab Expo , Booth 3135, being held at the...Read more
2013 06 Sep
Hospital laboratories outside the U.S. can benefit from a continued availability of the B·R·A·H·M·S PCT™ assay on ADVIA Centaur® systems, allowing them to diagnose sepsis early and safely. Thermo Fisher and Siemens Healthcare Diagnostics renew their non-exclusive, long-term, royalty-bearing agreement for the use of...Read more